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Bacterial colonization of the lower airways in patients with chronic bronchitis (CB) has been described mainly in
patients with co-existing chronic obstructive pulmonary disease (COPD). Although smoking has been identified as
a risk factor for bacterial colonization it is not known whether asymptomatic smokers (AS) can be colonized. The
aim of this study was to study lower airway bacterial colonization in smokers with stable CB and recurrent
exacerbations and compare with AS and healthy never-smokers (NS).
Thirty-nine smokers with CB and recurrent exacerbations (median FEV1 85% of predicted normal), 10 AS and
10 NS, underwent broncoscopy and a two-step bronchoalveolar lavage (BAL) procedure where the first portion
(20ml, ‘pre-BAL’) was recovered separately from the rest (140ml, ‘BAL’). The degree of oropharyngeal
contamination of pre-BAL and BAL samples was evaluated by cytology. Semiquantitative bacterial cultures were
performed on all samples.
Higher bacterial numbers than 103 colony-forming units (cfu)6ml71 in BAL were found only in the two
smoking groups. Using 103 cfu6ml71 as cut-o , 6/10 (60%) in the AS-, and 7/35 (20%) in the CB-group were
colonized in the lower airways. In all, 29% of all smokers had bacterial colonization. Only bacteria belonging to the
normal oropharyngeal flora were found. The proportion of samples with oropharyngeal contamination was
significantly lower in BAL than in pre-BAL (5% vs. 21%, P=0?039). The proportion of sterile samples was
significantly higher in BAL than in pre-BAL (49% vs. 26%, P=0?002).
Lower airway bacterial colonization was found both in asymptomatic smokers and in patients with CB.
Colonization with potential respiratory pathogens is uncommon in patients with CB and recurrent exacerbations
without severe airflow obstruction. The two-step BAL procedure seems to decrease oropharyngeal contamination.
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In smokers with chronic bronchitis (CB) with or without
chronic airflow obstruction, recurrent exacerbations are
common. Acute exacerbations in patients with severe
obstructive airway disease often require hospitalization
(1,2), and are responsible for substantial healthcare costs in
many countries (3).
Acute exacerbations are in most cases associated with
viral or bacterial infection (4,5). In approximately 50% of
acute exacerbations high numbers of bacteria can be
isolated from the lower airways (6,7). The bacterial species
most frequently associated with these exacerbations are thePaper received 28 February 2000 and accepted 28 March 2000.
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gens Haemophilus influenzae (HI), Moraxella catarrhalis
(MC) and Streptococcus pneumoniae (SP) (7,8).
The presence and role of bacterial colonization in the
lower airways in-between acute exacerbations has been a
focus of research interest in recent years (7,9–12). Using
invasive sampling methods and careful precautions to avoid
oropharyngeal contamination, these studies have indicated
colonization rates in patients with CB varying from 22% up
to 80%, depending on how colonization was defined.
Colonizing bacteria were found to be not solely potential
pathogens (HI, MC and SP), but also bacteria belonging to
the normal oropharyngeal flora (a-haemolytic streptococci,
Neisseria spp., Corynebacterium spp.).
In these studies, patients with rather advanced obstruc-
tive airway disease were investigated, and the bacteriologi-
cal sampling was performed with a protected specimen
brush (PSB) and limited to the large airways in all but one
(10). In two of these studies (11,12), current smoking was# 2000 HARCOURT PUBLISHERS LTD
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However, asymptomatic smoking controls were not in-
cluded in any of these studies and it is therefore unknown
whether bacterial colonization of the lower airways is
linked to the disease process or if it is a phenomenon
associated with smoking as such also in the absence of CB.
In addition, whether bacterial colonization extends beyond
the large airways is not clear, although indications of this
was recently presented (10).
We decided to study bacterial colonization of the lower
airways in patients with CB and a history of recurrent
exacerbations and compare with smokers without symp-
toms of inflammatory airways disease and healthy never-
smokers. The aims were two-fold, (i) to investigate the
possible association of smoking with presence of bacterial
colonization and, (ii) to evaluate a two-step BAL technique
for bacteriological sampling of the lower airways.
Materials and methods
DESIGN
The study was a bronchoscopic investigation of lower
airway bacterial colonization in clinically well-defined
subject groups. All subjects were evaluated for inclusion
at a preliminary visit during which a medical examination,
a test of ventilatory lung function and a pulmonary
radiograph was performed. Eligible subjects underwent
fibreoptic bronchoscopy 0–12 weeks later. All bronchosco-
pies were performed in an infection-free interval.
The study was performed at the Department of
Respiratory Medicine at Sahlgrenska University Hospital,
Go¨teborg, Sweden, and subjects were recruited from
patient files and by advertisement in a daily newspaper.
The study was approved by the Ethics Committee at the
Go¨teborg University. The subjects gave their written
consent after receiving both written and verbal information.
STUDY POPULATION
Three dierent subject groups were studied. The first was
composed of healthy never-smokers (NS) with normal
ventilatory lung function defined as forced expiratory
volume in 1 sec (FEV1 )4 80% of predicted normal based
on age, sex and height (pred). Asymptomatic smokers (AS)
with normal ventilatory lung function as defined above
made up the second control group. All were to be current
smokers, having smoked at least 10 cigarettes per day for
more than 10 years without fulfilling the American
Thoracic Society (ATS) criteria of chronic bronchitis (13).
The third group were to have symptoms of CB as defined
by ATS (13), i.e. chronic or recurrent productive cough on
most days for a minimum of 3 months per year during the
past 2 years. Co-existing chronic airway obstruction defined
as FEV1 5 80% pred was allowed. All were to be current
smokers, having smoked at least 10 cigarettes per day for
more than 10 years, and to have a history of two or more
acute exacerbations during the past 12 months as defined byBoman et al. (14). The total number of exacerbations
during the past 2 years was recorded.
For safety reasons all subjects were to be5 70 years old.
Criteria for exclusion were: a baseline FEV1 5 40%
pred, a post-bronchodilator increase in FEV14 15% pred,
an abnormal chest radiograph, bronchial hypersecretion
caused by other active pulmonary diseases such as
sarcoidosis or cystic fibrosis, known immunodeficiency,
a1-antitrypsin deficiency, a history of asthma, or subjects
with concurrent severe diseases.
Bronchoscopy was performed at least 4 weeks after
resolution of any symptoms of infectious respiratory
disease or any other infection with systemic symptoms
(fever, malaise etc.), after cessation of treatment with N-
acetylcysteine or antibiotics and at least 8 weeks after any
glucocorticosteroid treatment, whether local or systemic.
VENTILATORY LUNG FUNCTION
Ventilatory lung function (FEV1 % pred) was measured
with a Vitalograph Alpha (Vitalograph Ltd, Burkingham,
U.K.) in a standardized manner according to the directions
of the European Respiratory Society (15).
CLINICAL CHEMISTRY AND
HAEMATOLOGY
Immediately preceding bronchoscopy, 5ml of venous blood
was drawn for analysis of haemoglobin, platelet count,
leucocytes (total and dierential count) and C-reactive
protein (CRP). The Sahlgrenska University Hospital
laboratory’s instructions for handling of samples and its
reference ranges for normality were used.
FIBRE-OPTIC BRONCHOSCOPY
Premedication was given as oral diazepam (5–10mg)
together with 0?5–1ml morphine–scopolamine
(10mg6ml710?4mg6ml71) i.m. 45min before broncho-
scopy. Local anaesthesia of the oropharynx was given as
1% tetracaine sprayed by a deVilbiss (deVilbiss Ltd.,
Heston, UK) aerosol device (*4ml), followed by addi-
tional (2–3ml) instillation of tetracaine into the larynx. The
tetracaine solution was prepared without any preservatives
by the hospital pharmacy and has no significant antibacter-
ial activity (9). All bronchoscopies were performed transo-
rally by one of two experienced bronchoscopists, and with
the subject in the supine position. Olympus flexible fibre-
optic bronchoscopes (Olympus Optical Co., Tokyo, Japan)
of several models were used.
COLLECTION OF SAMPLES
The bronchoscope was introduced into the trachea and
advanced into the right middle lobe bronchus where 1–2ml
of 1% tetracaine was given to anaesthetize the middle lobe
bronchus. No suction was applied prior to sampling. The
bronchoscope was wedged in a subsegmental bronchus for
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contamination of the BAL sample this was performed in
two steps. First, 20ml of sterile pyrogen-free phosphate-
buered saline (PBS) with a pH of 7?3 and a temperature of
378C was instilled and immediately aspirated into a
siliconized glass container. This specimen, referred to as
‘pre-BAL’, was processed separately. Secondly, without
moving the bronchoscope, a further 80+60ml of PBS was
instilled, immediately aspirated and pooled in another
siliconized glass container. This sample is referred to as
‘BAL’. The pre-BAL and BAL samples were then
immediately transported to the microbiological laboratory
for processing.
BACTERIAL CULTURES
Quantitative methods for bacterial cultures were used.
From the pre-BAL and BAL samples 0?01ml were plated
onto each of a series of plates with horse blood agar (two
plates), modified Drigalski agar for Gram-negative bacter-
ia, enriched haematin agar, Saboraud agar for yeast, horse
blood chocolate agar supplemented with X and V factors,
vancomycin and bacitracin for the selective growth of
Haemophilus influenzae and a two-layer blood agar contain-
ing oxolinic acid and colistin for selective growth of
streptococci. One horse blood agar plate was incubated
anaerobically for 48 h, the plate for selective growth of
streptococci anaerobically for 24 h, then aerobically for
another 24 h. The remaining plates were incubated for 48 h
aerobically with or without 5% CO2 as appropriate. All
plates were incubated at 378C. Routine bacteriological
methods for identification of bacteria were used (16). The
detection limit for the pre-BAL and BAL cultures were 100
colony forming units (cfu)6ml71.
Evaluation of pre-BAL and BAL sample representativity
was done in a standardized manner as described and
evaluated previously by Kahn et al. (17). Briefly, the pre-
BAL and BAL fluid samples were centrifuged at 3000 rpm
for 10min. One droplet (*50ml) of the cell-pellet was
placed on a slide and Gram-stained. The preparations were
examined by light microscopy with a power of magnifica-
tion of 100 and the fraction of squamous epithelial cells in
relation to total number of inflammatory cells was assessed.
Samples containing 51% squamous epithelial cells were
considered representative of the lower airways.
STATISTICAL CONSIDERATIONS
A StatView1 4?5 (Abacus Concepts, Berkeley, CA, U.S.A.)
software package was used for the statistical analysis. Since
most of the data did not show a normal distribution, data
are presented as median and range unless otherwise stated.
For comparisons between subject groups, a Wilcoxon rank
sum test or a Fisher’s exact test was performed. For
comparison between pre-BAL and BAL samples a test of
confidence interval (CI) for two paired proportions using
the continuity correction was applied (18). All tests were
two-tailed and P-values 5 0?05 were accepted as signifi-
cant. A Spearman rank correlation coecient was calcu-lated to analyse possible correlations between culture
results and clinical variables.
Results
A total of 68 recruited subjects (48 CB, 10 AS and 10 NS)
fulfilled all inclusion criteria at the first visit. Of these, 59
underwent broncoscopy and completed the study. Nine
subjects, all CB patients with recurrent infectious exacer-
bations, did not complete the study. Two were excluded
after the first visit due to opacities on chest radiograph.
They were followed up in the tumour investigation
programme of the clinic. After initial consent, seven
subjects later declined to undergo fibre-optic bronchoscopy.
There were no significant dierences in demographic or
clinical characteristics between the nine CB dropouts and
the 39 CB patients who completed the study.
The demographic and clinical data of the study popula-
tion are summarized in Table 1. The asymptomatic smokers
diered significantly from the CB group with regard to
smoking history with, on average, a lower number of pack-
years. However, current smoking habits were not signifi-
cantly dierent. Ventilatory lung function was significantly
lower in the CB group. In the CB group, 14 out of 39 (36%)
subjects had mild chronic airflow obstruction (median
FEV1 % pred 70; range 61–79). This subgroup of subjects
with chronic obstructive pulmonary disease (COPD) did
not dier significantly in any other way from the 25 non-
obstructive subjects within the CB group (data not shown).
HAEMATOLOGY AND CLINICAL
CHEMISTRY
There were no significant dierences in haemoglobin level,
eosinophil and platelet counts between the groups. Total
leucocyte (WBC) and neutrophil (PMN) counts were
significantly higher in all smokers compared with never-
smokers (WBC: 7?0+1?6 vs. 5?1+0?96109/l, P50?001;
PMN: 3?9+1?4 vs. 2?7+0?46109/l, P50?01, mean+SD)
and in CB patients compared with never-smokers (WBC:
7?0+1?5 vs. 5?1+0?96109/l, P50?001; PMN: 4?0+1?3 vs.
2?7+0?46109/l, P50?01, meanSD). However, no abnor-
mal values of clinical significance for any of the haemato-
logical parameters were observed. All but one measurement
of CRP were below the detection limit, i.e.510mg l71. The
exception was one otherwise asymptomatic subject in the
CB group with a CRP value of 39mg l71.
BACTERIOLOGICAL ANALYSES
Methodological evaluation
Pre-BAL and BAL samples were obtained in 58 and 57 out
of 59 subjects, respectively. Twelve out of 58 (21%) pre-
BAL samples had 41% squamous epithelial cells on
examination of Gram-stained slides. The corresponding
figure for BAL samples was three out of 57 (5%). The
proportion of samples with this sign of oropharyngeal
FIG. 1. Percentage of cultures with growth of bacteria in
pre-BAL and BAL. : All samples;&: smokers;&: never
-smokers; BAL: bronchoalveolar lavage.
TABLE 1. Demographic and clinical data of the study population
Never-smokers Asymptomatic smokers CB with exacerbations
n 10 10 39
Age, years 55 (37–64) 44 (34–60) 51 (37–68)
FEV1 % pred 103
a (91–120) 113b (95–129) 85 (61–111)
Pack-years 0 25c (11–62) 35 (13–88)
Current smoking,
cigarettes x day71 0 15 (10–30) 20 (10–40)
Male/female 5/5 3/7 9/30
Duration of CB (years) 0 0 10 (4–30)
No. of exacerbations in 2 years 0 0 6 (4–20)
Data are presented as median values with range in parenthesis. CB: chronic bronchitis; FEV1: forced expiratory volume in
1 sec; a: never-smokers vs. CB group, P50?001; b: asymptomatic smokers vs. CB group, P50?001; c: asymptomatic smokers
vs. CB group, P50?01.
FIG. 2. Percentage of individuals with bacterial isolates in
intervals according to number of colony-forming units
(cfu6ml71) in, a) pre-BAL and b) BAL. &: never-
smokers; : asymptomatic smokers; &: chronic
bronchitis with recurrent exacerbations. Dotted line
marks cut-o for colonization. BAL: bronchoalveolar
lavage.
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BAL (P=0?039, 95% CI: 0?03; 0?28). The percentages of
samples in pre-BAL and BAL with growth of bacteria in all
subjects and divided by smoking status are shown in Fig. 1.
The proportion of cultures with growth of bacteria was
significantly lower in BAL than in pre-BAL samples (51%
vs. 74%, P=0?002). There was a greater dierence in never-
smokers than in smokers (40% vs. 20%) between the
proportions of cultures with growth of bacteria in pre-BAL
and BAL samples but this dierence was not significant.
Bacteriological results
There were no significant dierences between the study
groups in the fraction of cultures with bacterial growth
(positive), or in the numbers of bacteria in positive cultures
either in pre-BAL or in representative BAL samples. The
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isolates in dierent intervals according to number of
cfu6ml71 are shown in Fig. 2(a and b). In pre-BAL,
potential respiratory pathogens were isolated in two
subjects: H. influenzae 103 cfu6ml71 in one CB subject,
and Staphylococcus aureus 500 cfu6ml71 in one AS
subject. These pathogens were not isolated in the corre-
sponding BAL samples. In all other cases bacteria
belonging to the normal oropharyngeal flora (a-haemolytic
streptococci, Neisseria spp. coagulase negative staphylo-
cocci, Corynebacterium spp. etc.) were isolated, with a-
streptococci dominating quantitatively. No strictly anaero-
bic bacteria were isolated.
Three BAL samples had more than 1% squamous
epithelial cells, two from the CB group and one from the
NS group. They were accordingly excluded from further
analyses because of suspected contamination. No subject in
the NS group had a BAL culture with 4103 cfu6ml71.
Significant growth, i.e. bacterial colonization, was
defined using a cut-o determined by the highest number
of bacteria isolated in a culture from a representative BAL
sample in the NS group (103 cfu6ml71). Accordingly,
bacterial colonization was found in six out of 10 (60%,
95% CI: 30; 90) subjects in the AS group and in seven out
of 35 (20%, 95% CI: 7; 33) in the CB group. In the CB
group, three out of 14 (21%) obstructive and four out of 21
(19%) non-obstructive subjects were colonized. There was
no significant dierence between the AS and CB groups in
the numbers of bacteria in colonized subjects. However, the
fraction of colonized subjects was significantly greater in
the AS group (P50?05, 95% CI: 7; 73). Taking all smokers
together, intrabronchial colonization was found in 13 out
of 45 (29%, 95% CI: 16; 42) subjects. Colonized subjects
did not dier significantly from non-colonized with respect
to amount of current smoking or number of pack-years
(data not shown).
ANALYSIS OF POSSIBLE FACTORS
MODIFYING THE LOWER AIRWAY
BACTERIAL FLORA
There was no significant correlation between bacterial
numbers in BAL samples and duration of chronic
bronchitis, number of exacerbations the past 2 years,
FEV1, smoking history or current smoking habits. In the
smoking groups colonized subjects were compared with
non-colonized with respect to the above mentioned clinical
variables. No significant dierences between the groups
were found.
Discussion
The main finding in this study is that not only patients with
chronic bronchitis and a history of infectious exacerbations,
but also asymptomatic smokers with normal ventilatory
lung function can be colonized with bacteria in the lower
airways. To our knowledge, no previously published studies
of airway colonization have included a group of asympto-matic smokers (7,9–12,19–21), and since the AS group in
our study is small, caution is needed when interpreting our
results. In spite of the small group size, we feel that our
results put earlier studies in perspective and indicate that
future studies on airway colonization in CB and COPD
should include both an AS and a NS group. Interestingly,
bacterial colonization was not more frequent in heavy
smokers, a connection found in a previous study (20), nor
was there any correlation between colonization and number
of exacerbations, or degree of airflow obstruction in the CB
group.
The fraction of colonized smokers in the present study
(29%), is comparable to the fraction of colonized patients
with CB in earlier studies by Riise et al. (24%) (9) and two
studies by Monso´ et al. (25% and 22%) (7,12). However,
the results dier when the colonizing bacterial species are
considered. We found no respiratory pathogens, whereas in
earlier studies respiratory pathogens were isolated in a few
(9), or in as much as half or more of the colonized subjects
(7,12). One possible explanation is that the earlier studies
sampled the large proximal airways using PSB and there-
fore their results may not be naturally comparable with
ours. Another might be the fact that we included an AS
group with normal lung function, and only 14 out of 35 CB-
patients with mild chronic airflow obstruction, whereas in
the studies by Monso´ et al. all had moderate or severe
airflow obstruction.
An essential methodological problem in all studies
investigating the microbiology of the lower airways is the
risk to contaminate the samples with oropharyngeal flora.
Due to this, cultures of expectorated sputum has been
shown to be inadequate both in diagnosing lower airway
infections (22,23) and in studies of lower airway coloniza-
tion in patients with obstructive CB (20). Transtracheal
needle-aspiration through the cricoid membrane was
proven a more reliable method by Irwin et al. (20).
However, this method obtains specimens from the trachea
and does not reach the peripheral airways, and orophar-
yngeal secretions are sometimes inhaled during the proce-
dure (19).
The broncoscopically guided PSB method for obtaining
uncontaminated samples of the lower airways first discribed
by Wimberly et al. (24) has been extensively used in the
diagnosis of lung infections. In this method, topical
anaesthesia of the larynx and proximal parts of the
bronchial tree is achieved through inhalation of sterile
local anaesthetic preceding the bronchoscopy, and no
further local anaesthetic is then given through the
bronchoscope until after completion of the bacteriological
sampling. Although bronchi at the subsegmentary level can
be reached with this method, it is a method mainly
sampling the large conducting airways.
Fiberoptic bronchoscopy and BAL performed with
suciently large volumes (minimum 100ml) samples the
peripheral airways and a large area of the airway mucosa
(25), and is therefore an attractive method for the study of
bacterial colonization in the peripheral airways. However,
it has previously been shown that when the inner channel of
the broncoscope is used to administer topical anaesthesia,
BAL samples from healthy non-smoking subjects can be
886 I. QVARFORDT ET AL.contaminated with bacteria of oropharyngeal origin, albeit
in low numbers (26). This is also the case when the
Wimberly method of anaesthesia is used before PSB
sampling (22,24). Occasional recovery of bacteria from
the lower airways in healthy never-smoking subjects can,
apart from contamination during the sampling procedure,
be due to intermittent aspiration of small numbers of
bacteria from the oral cavity. In the diagnosis of acute
pulmonary infections this problem can be overcome by
establishing a cut-o for significant growth, usual-
ly103 cfuml71 for PSB and105 cfuml71 for BAL
(17,27), validated by comparison with other diagnostic
criteria. Defining significant growth in studies of bacterial
colonization is a more complex task since no clinically
defined condition to compare a proposed bacteriological
cut-o with exists. The PSB cut-o for significant growth in
pulmonary infections (103 cfu6ml71) was, however, shown
to perform well also in one study of airway colonization (9),
but no corresponding cut-o for BAL has so far been
established. In other previous studies the cut-o level for
colonization was arbitrarily chosen regardless of whether
PSB or BAL was used (7,10–12,21). In contrast to this, we
used culture results from the control group of healthy
never-smokers to establish a cut-o for significant growth,
i.e. colonization.
In the present study, conventional methods for local
anaesthesia of the larynx and the bronchial tree were used
and alternative methods to control and minimize orophar-
yngeal contamination and evaluate sample representativity
were adopted. Discarding the first aliquot of BAL fluid to
minimize the risk of contamination has been practised by
other researchers (10,28), and the present study indicates
the rationality of this procedure. The dierences in culture
results between pre-BAL and BAL samples point in this
direction, especially when the NS and the smoking groups
are compared (Fig. 1). Furthermore, presence of 41%
squamous epithelial cells in BAL samples accurately
identified heavy oropharyngeal contamination in a metho-
dological study by Kahn et al. (17), and this method has
since been used by several researchers (28–30). In the
present study, the rate of contamination according to this
criterion was much higher in the pre-BAL than in the BAL
samples (21% vs. 5%), which indicates that discarding the
first aliquot may decrease the risk of contamination in the
BAL cultures. All BAL samples with this sign of
contamination were accordingly excluded from further
analysis. Furthermore, we decided to let the highest number
of bacteria present in a NS sample define the cut-o for
colonization. By applying these strict criteria for coloniza-
tion we feel convinced that the number of colonized
subjects is not overestimated. It does however increase the
risk that individuals colonized with low numbers of bacteria
are overlooked. We are aware that the described method
needs further evaluation, but nevertheless propose its use as
an alternative method in studies of bacterial colonization of
peripheral airways.
To conclude, our data suggest that smoking is associated
with colonization of the lower airways with bacteria
belonging to the normal oropharyngeal flora, even in the
absence of symptomatic smoking-induced inflammatoryairways disease, i.e. chronic bronchitis. In addition, our
data suggest that colonization with respiratory pathogens is
uncommon in patients with CB without severe airflow
obstruction.
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